EPZM - Epizyme Inc
Close
1.47
-0.020 -1.361%
Share volume: 0
Last Updated: Thu 11 Aug 2022 10:00:01 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.49
-0.02
-1.34%
Summary score
26%
Profitability
25%
Dept financing
6%
Liquidity
71%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.2%
Return on assets
-12.49%
Return on sales
-3062.95%
Return on invested capital
224.49%
Total debt ratio
18.55%
Debt ratio change over timeo
-0.92%
Current Ratio
11.15%
Quick Ratio
12.99%
Cash Position Ratio
4.5%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.05%
Return on assets
-12.39%
Return on sales
-3062.95%
Return on invested capital
403.56%
Total debt ratio
22.79%
Debt ratio change over timeo
-0.99%
Current Ratio
12.22%
Quick Ratio
12.99%
Cash Position Ratio
4.41%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-19.92%
Return on assets
-13.47%
Return on sales
-2333.44%
Return on invested capital
-138.96%
Total debt ratio
31.36%
Debt ratio change over time
-1.14%
Current Ratio
11.57%
Quick Ratio
11.25%
Cash Position Ratio
3.82%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.65%
Return on assets
-106.57%
Return on sales
296.58%
Return on invested capital
44.32%
Total debt ratio
-91.67%
Debt ratio change over time
-0.92%
Current Ratio
4.88%
Quick Ratio
-3.01%
Cash Position Ratio
1.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EPZM | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -15.2% | 0% | 0% | 29.06% |
| Return on assets | -12.49% | 0% | 0% | -9.75% |
| Return on sales | -3062.95% | 0% | 0% | -1469.44% |
| Return on invested capital | 224.49% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 50% | 30% |
| Total debt ratio | 18.55% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.92% | 0% | 0% | 19.02% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 12.22% | 0% | 0% | 5.9% |
| Quick Ratio | 12.99% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.41% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 40% |
| Short-term ratios | EPZM | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -16.05% | 0% | 0% | -16.12% |
| Return on assets | -12.39% | 0% | 0% | -14.95% |
| Return on sales | -3062.95% | 0% | 0% | -3498.94% |
| Return on invested capital | 403.56% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 75% | 6% |
| Total debt ratio | 22.79% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.99% | 0% | 0% | 0.09% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 12.22% | 0% | 0% | 5.9% |
| Quick Ratio | 12.99% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.41% | 0% | 0% | 5.68% |
| Liquididy | 69% | 0% | 0% | 48% |